ICLR ICON Plc

ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research

, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured with numerous awards in the second half of 2024.

On TIME Magazine’s 2024 list of World’s Best Companies ICON was ranked as the highest clinical research organisation out of 1,000 companies for the second year in a row, and in its 2025 list of World’s Best Companies in Sustainable Growth it was featured at number 57 out of 500 companies. ICON was also announced as a winner of the Best Practices Recognition award from the Frost and Sullivan Institute’s Enlightened Growth Leadership awards.

ICON was also honoured with a 2024 Scrip award for Best Contract Research Organisation (Full Service Providers). These awards acknowledge the critical role of CROs in delivering specialist outsourced services for all aspects of clinical trials. This is the fifth time ICON has won this coveted industry award in the last eight years.

Two members of ICON’s executive leadership team were acknowledged for professional accomplishment. Barry Balfe was named to the 2024 PharmaVoice 100 List, which recognises the most inspiring leaders in life sciences. Rose Kidd was announced as the recipient of the Businesswoman Award at the 2024 Women Mean Business Awards in Ireland. Additionally, Alexander Murray, an ICON validation specialist, was named IRT Young Professional 2024 at this year’s annual Interactive Response Technology (IRT) Professionals’ Day, celebrating IRT and clinical supply excellence across the industry.

ICON was also recognised across a range of creative and digital marketing awards. Its Creative & Digital Services and Patient Recruitment Services teams won two Health + Wellness awards from Graphic Design USA for the TANGO and ADAMANT study materials, and a Gold Award and Honourable Mention at the MarCom Awards for the same studies in the in the category of “Strategic Communications | Communications/Public Relations | Research/Study.” The MarCom Awards further awarded ICON a Platinum honour for the UCB BE OPEN Study Materials in the same category. ICON also received the Rx Club Show Award of Excellence in the “Direct to Consumer” category.

ICON’s FIRECREST medical animation video, “The Invisible Machine,” won a gold MUSE award whilst at the 2024 Annual International Business Awards, ICON won two Stevie® Awards: Gold for a technology video showcasing AI platforms and wearables, and Bronze for the CARD system, which enhances clinical data distribution. At the 2024 Awards for Technical Excellence, ICON also won a Silver Stevie® for eClinical Development & Delivery’s tokenisation solution.

Steve Cutler, CEO, ICON commented: “It’s fantastic to end the year with recognition for both individual employees as well as ICON as a company. I’m incredibly proud of all the teams and individuals who were honoured in these awards, which demonstrate ICON’s commitment to delivering value and quality in the field of clinical research.”

A full list of ICON’s industry awards can be viewed at .

About ICON plc

ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 42,250 employees in 106 locations in 55 countries as at September 30, 2024. For further information about ICON, visit: .

ICON/ICLR-G

EN
23/12/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ICON Plc

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

 PRESS RELEASE

ICON plc to Present at Upcoming Investor Conferences

DUBLIN--(BUSINESS WIRE)-- , (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Leerink Partners Global Healthcare Conference on Wednesday, March 12, 2025 at 8.00 am ET and at the Barclays 27th Annual Global Healthcare Conference on Thursday, March 13, 2025 at 8.30 am ET. Any changes to these events and links to the live webcasts will be posted on the Investor section of our website under “”. About ICON plc ICON plc is a world-leading healthcare intelligence and clinical...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

ICON Reports Fourth Quarter and Full Year 2024 Results

DUBLIN--(BUSINESS WIRE)-- ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today reported its financial results for the fourth quarter and full year ended December 31, 2024. CEO, Dr. Steve Cutler commented, “ICON’s results in quarter four were in-line with our expectations as we continue to manage through a challenging transition period in our business. Encouragingly, we saw progress in a number of key areas in quarter four. Gross business wins increased 8% sequentially, indicative of a positive, albeit volatile, underlying demand environme...

 PRESS RELEASE

ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies

DUBLIN--(BUSINESS WIRE)-- , (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of that deliver efficiencies across the clinical trial process, including study startup, document management, resource forecasting and metrics reporting. ICON has invested significantly in its AI and digital capabilities through the establishment of its AI Centre of Excellence. The centre, which comprises a dedicated team of data scientists, engineers and domain experts, is responsible for developing and deploying AI sol...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch